Medicare Enrolled
Dr. Ryan Drake, DO
Neurology · Canton, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Drake from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Drake?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Drake
Dr. Ryan Drake is a neurology specialist in Canton, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Drake performed 14,727 Medicare services across 930 unique beneficiaries.
Between the years covered by Open Payments, Dr. Drake received a total of $272,895 from 95 pharmaceutical and/or device companies across 1827 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Drake is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in OH
$272,895 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,727
Medicare services
Top 4% in OH for neurology
930
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~775 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| AbobotulinumtoxinA injection, 5 units An injection of abobotulinumtoxinA administered in a quantity of 5 units. |
13,510 | $7 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
817 | $84 | $188 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
145 | $114 | $247 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
58 | $119 | $294 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 48 | $57 | $106 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
43 | $98 | $239 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $52 | $133 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $117 | $266 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
20 | $27 | $60 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $103 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$272,895
Total received (2018-2024)
Avg $38,985/year across 7 years
Top 5% in OH for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
95
Companies
1,827
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$240,743 (88.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,851 (8.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,301 (3.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$65,671
2023
$18,709
2022
$47,809
2021
$44,408
2020
$52,908
2019
$31,681
2018
$11,708
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$26,577
Alexion Pharmaceuticals, Inc.
$24,068
ARGENX US, INC.
$7,009
UCB, Inc.
$2,981
Amneal Pharmaceuticals LLC
$1,231
ABBVIE INC.
$710
Teva Pharmaceuticals USA, Inc.
$266
TG Therapeutics, Inc.
$260
ACADIA Pharmaceuticals Inc
$206
EMD Serono, Inc.
$187
JAZZ PHARMACEUTICALS INC.
$185
PFIZER INC.
$184
SK Life Science, Inc.
$162
Eisai Inc.
$158
Neurocrine Biosciences, Inc.
$143
Avadel CNS Pharmaceuticals, LLC
$126
Lundbeck LLC
$124
Amgen Inc.
$102
Genentech USA, Inc.
$90
Axsome Therapeutics, Inc.
$88
Takeda Pharmaceuticals U.S.A., Inc.
$75
Vanda Pharmaceuticals Inc.
$73
Corium, LLC
$66
Xeris Pharmaceuticals, Inc.
$66
HARMONY BIOSCIENCES LLC
$65
Neurelis, Inc.
$59
Alnylam Pharmaceuticals Inc.
$55
Otsuka America Pharmaceutical, Inc.
$50
Aucta Pharmaceuticals, Inc.
$47
CATALYST PHARMACEUTICALS, INC.
$34
Biogen, Inc.
$32
Celgene Corporation
$32
Novartis Pharmaceuticals Corporation
$24
Kyowa Kirin, Inc.
$23
Grifols USA, LLC
$20
Acorda Therapeutics, Inc
$19
Itamar Medical Inc
$17
GE HEALTHCARE
$15
Ipsen Biopharmaceuticals, Inc
$14
Amylyx Pharmaceuticals, Inc.
$14
Merz Pharmaceuticals, LLC
$13
Top 3 companies account for 87.8% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$87,474
Teva Pharmaceuticals USA, Inc.
$66,107
SK Life Science, Inc.
$35,302
Lilly USA, LLC
$27,006
Neurocrine Biosciences, Inc.
$12,080
Biohaven Pharmaceuticals, Inc.
$7,736
ARGENX US, INC.
$7,529
UCB, Inc.
$6,364
Neurocrine BioSciences, Inc.
$3,375
Amneal Pharmaceuticals LLC
$1,395
Amgen Inc.
$1,247
Novartis Pharmaceuticals Corporation
$1,237
ABBVIE INC.
$1,109
EMD Serono, Inc.
$1,017
GENZYME CORPORATION
$946
AbbVie Inc.
$914
JAZZ PHARMACEUTICALS INC.
$827
Eisai Inc.
$690
Lundbeck LLC
$659
Genentech USA, Inc.
$611
ACADIA Pharmaceuticals Inc
$603
Biogen, Inc.
$568
Celgene Corporation
$474
Sunovion Pharmaceuticals Inc.
$448
Kyowa Kirin, Inc.
$424
PFIZER INC.
$405
Allergan, Inc.
$325
Janssen Pharmaceuticals, Inc
$303
TG Therapeutics, Inc.
$260
Harmony Biosciences LLC
$247
Avanir Pharmaceuticals, Inc.
$236
Biohaven Pharmaceutical Holding Company Ltd.
$228
Supernus Pharmaceuticals, Inc.
$224
Jazz Pharmaceuticals Inc.
$200
E.R. Squibb & Sons, L.L.C.
$191
Xeris Pharmaceuticals, Inc.
$191
EISAI INC.
$178
Axsome Therapeutics, Inc.
$174
Avadel CNS Pharmaceuticals, LLC
$172
Vanda Pharmaceuticals Inc.
$168
Horizon Therapeutics plc
$165
Takeda Pharmaceuticals U.S.A., Inc.
$158
HARMONY BIOSCIENCES LLC
$155
Neurelis, Inc.
$143
Sumitomo Pharma America, Inc.
$138
Acorda Therapeutics, Inc
$135
TG THERAPEUTICS, INC.
$131
Avion Pharmaceuticals
$123
Bausch Health US, LLC
$103
NEUROPACE, INC.
$103
Neos Therapeutics, LP
$101
UPSHER-SMITH LABORATORIES LLC
$89
AbbVie, Inc.
$88
Corium, LLC
$84
CSL Behring
$73
IMPEL PHARMACEUTICALS INC.
$68
Scilex Pharmaceuticals Inc.
$68
Grifols USA, LLC
$64
Strongbridge US INC.
$63
Promius Pharma LLC
$62
Adamas Pharmaceuticals, Inc.
$61
Merck Sharp & Dohme Corporation
$59
Mitsubishi Tanabe Pharma America, Inc.
$56
Ironshore Pharmaceuticals Inc.
$56
Alnylam Pharmaceuticals Inc.
$55
Mallinckrodt Hospital Products Inc.
$53
Otsuka America Pharmaceutical, Inc.
$50
US WorldMeds, LLC
$47
Aucta Pharmaceuticals, Inc.
$47
Greenwich Biosciences, Inc.
$46
Inspire Medical Systems, Inc.
$46
GE HealthCare
$44
Impax Laboratories, Inc.
$43
GE HEALTHCARE
$40
CATALYST PHARMACEUTICALS, INC.
$34
Nevro Corp.
$34
Assertio Therapeutics, Inc.
$34
MITSUBISHI TANABE PHARMA AMERICA, INC.
$28
Collegium Pharmaceutical, Inc.
$28
Vertical Pharmaceuticals, LLC
$28
Catalyst Pharmaceuticals, Inc.
$27
Abbott Laboratories
$25
Merz North America, Inc.
$21
Flowonix Medical Incorporated
$20
Merck Sharp & Dohme LLC
$18
Itamar Medical Inc
$17
ARBOR PHARMACEUTICALS, INC.
$16
Ipsen Biopharmaceuticals, Inc
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Amylyx Pharmaceuticals, Inc.
$14
Cala Health, Inc.
$14
Merz Pharmaceuticals, LLC
$13
GE Healthcare
$13
Upsher-Smith Laboratories LLC
$12
Advanced Respiratory, Inc
$11
Top 3 companies account for 69.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · AZSTARYS · Adzenys XR-ODT · Aimovig · Austedo XR · Azstarys · BELSOMRA · BOTOX · BRIUMVI · Briviact · CALA TRIO · COMIRNATY · COPAXONE · Cambia · Cenobamate · DUOPA · Dhivy · Duopa · Dysport · ELIQUIS · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Evrysdi · FABRY-DISEASE · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GVOKE PFS · Gamunex-C · Gralise · HYQVIA · Hetlioz · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · Infinity DBS Pulse Generators · Jornay PM 20mg capsules (Bottle of 100) · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LATUDA · LEMTRADA · LUMIZYME · LUMRYZ · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PAXLOVID · POMPE - DISEASE · PONVORY · Ponvory · Prometra II · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RNS Neurostimulator Kit · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · Senza · Serostim · Soliris · Sunosi · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · The Vest System Model 105 Home Care · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · WatchPATONE · XARELTO · XCOPRI · XEOMIN · XYREM · XYWAV · Xeomin · ZAVZPRET · ZEPOSIA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for neurology in OH.
Geographic Context
Neurologists within 10 mi
31
Per 100K population
8.3
County median income
$65,740
Nearest hospital
MERCY MEDICAL CENTER
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Drake is a mixed practice specialist, with above-average Medicare volume (top 4% in OH), with speaking/promotional industry engagement in the top 5% of OH peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Drake experienced with abobotulinumtoxina injection, 5 units?
Based on Medicare claims data, Dr. Drake performed 13,510 abobotulinumtoxina injection, 5 units services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Drake receive payments from pharmaceutical companies?
Yes. Dr. Drake received a total of $272,895 from 95 companies across 1,827 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Drake's costs compare to other neurologists in Canton?
Dr. Drake's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Drake) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Canton
Browse neurologists in Canton ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in OH
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in OH
Which OH neurologists receive the most from drug and device companies.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology